Peter E Schwartz

Peter E Schwartz

UNVERIFIED PROFILE

Are you Peter E Schwartz?   Register this Author

Register author
Peter E Schwartz

Peter E Schwartz

Publications by authors named "Peter E Schwartz"

Are you Peter E Schwartz?   Register this Author

99Publications

4027Reads

27Profile Views

Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning.

Obstet Gynecol 2019 Aug;134(2):227-238

Departments of Obstetrics, Gynecology and Reproductive Sciences and Internal Medicine, Yale School of Medicine, the Department of Biostatistics, Yale School of Public Health, the Yale Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, and the Yale School of Medicine, New Haven, Connecticut; CooperSurgical Inc., Trumbull, Connecticut; and the Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000003375DOI Listing
August 2019

Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.

Am J Obstet Gynecol 2019 Jul 7;221(1):39.e1-39.e14. Epub 2019 Mar 7.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT; Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, New Haven, CT. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00029378193043
Publisher Site
http://dx.doi.org/10.1016/j.ajog.2019.02.051DOI Listing
July 2019

Risk of unexpected uterine Cancer in women undergoing myomectomy: A population-based study.

Eur J Obstet Gynecol Reprod Biol 2019 Jul 20;238:188-190. Epub 2019 Mar 20.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT, United States; Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, New Haven, CT, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2019.03.021DOI Listing
July 2019

Adjuvant Hormonal Therapy for Low-Grade Endometrial Stromal Sarcoma.

Reprod Sci 2019 05 29;26(5):600-608. Epub 2018 May 29.

1 Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1933719118778801DOI Listing
May 2019

Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.

J Cancer Res Clin Oncol 2018 Dec 25;144(12):2449-2456. Epub 2018 Sep 25.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, 06520, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00432-018-2753-y
Publisher Site
http://dx.doi.org/10.1007/s00432-018-2753-yDOI Listing
December 2018

Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment.

Gynecol Oncol Rep 2018 Aug 24;25:41-44. Epub 2018 May 24.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2018.05.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014583PMC
August 2018

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report.

Gynecol Oncol Rep 2018 Aug 23;25:37-40. Epub 2018 May 23.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2018.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030029PMC
August 2018

In Reply.

Obstet Gynecol 2018 Aug;132(2):519-520

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000002770DOI Listing
August 2018

Mechanisms of resistance to HER2-targeted therapies in HER2-amplified uterine serous carcinoma, and strategies to overcome it.

Discov Med 2018 08;26(141):39-50

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
August 2018

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.

J Clin Oncol 2018 07 27;36(20):2044-2051. Epub 2018 Mar 27.

Amanda N. Fader, Johns Hopkins School of Medicine; Dana M. Roque, University of Maryland; Paul Celano, Greater Baltimore Medical Center, Baltimore; William Lowery, Walter Reed Medical Center, Bethesda, MD; Eric Siegel, University of Arkansas for Medical Sciences, Little Rock, AR; Natalia Buza, Pei Hui, Osama Abdelghany, Stefania Bellone, Masoud Azodi, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Peter E. Schwartz, and Alessandro D. Santin, Yale University School of Medicine, New Haven, CT; Setsuko K. Chambers, University of Arizona, Tucson, AZ; Angeles Alvarez Secord and Laura Havrilesky, Duke University School of Medicine, Durham, NC; David M. O'Malley and Floor Backes, The Ohio State University School of Medicine, Columbus, OH; Nicole Nevadunsky, Montefiore Medical Center, Bronx, NY; Babak Edraki, John Muir Medical Center, Walnut Creek, CA; Dirk Pikaart, Penrose Cancer Center-St Francis, Colorado Springs, CO; and Karim S. ElSahwi, Meridian Health, Neptune, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5966DOI Listing
July 2018

MicroRNA signatures discriminate between uterine and ovarian serous carcinomas.

Hum Pathol 2018 06 5;76:133-140. Epub 2018 Mar 5.

Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177183007
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2018.02.019DOI Listing
June 2018

Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.

Obstet Gynecol 2018 04;131(4):642-651

Departments of Obstetrics, Gynecology and Reproductive Sciences and Internal Medicine and the Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut; the Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York; and the Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000002521DOI Listing
April 2018

Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo.

Med Oncol 2017 May 10;34(5):91. Epub 2017 Apr 10.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, Rm. 305 LSOG, 333 Cedar Street, PO Box 208063, New Haven, CT, 06520-8063, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-017-0956-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896014PMC
May 2017

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1).

Gynecol Oncol Rep 2017 Feb 14;19:10-12. Epub 2016 Dec 14.

Department of Obstetrics & Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2016.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175991PMC
February 2017

Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1).

Gynecol Oncol Rep 2017 Feb 14;19:10-12. Epub 2016 Dec 14.

Department of Obstetrics & Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2016.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175991PMC
February 2017

Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.

Gynecol Oncol 2017 Jan 24;144(1):77-82. Epub 2016 Oct 24.

Yale University, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, P.O. Box 208063, New Haven, CT 06511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2016.09.027DOI Listing
January 2017

Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab.

Clin Cancer Res 2016 Dec 2;22(23):5682-5687. Epub 2016 Aug 2.

Department of Genetics, Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5135588PMC
December 2016

Correction of coagulopathy associated with non-bacterial thrombotic endocarditis (NBTE) by surgical debulking in a case of ovarian clear cell carcinoma.

Gynecol Oncol Rep 2016 Aug 7;17:13-5. Epub 2016 May 7.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2016.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899078PMC
August 2016

Chemotherapy for Elderly Ovarian Cancer Patients.

Gynecol Obstet (Sunnyvale) 2016 Aug 31;6(8). Epub 2016 Aug 31.

Section of Medical Oncology, Yale University School of Medicine, Yale Cancer Center, New Haven CT, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042145PMC
http://dx.doi.org/10.4172/2161-0932.1000397DOI Listing
August 2016

Microscopic Omental Metastasis in Clinical Stage I Endometrial Cancer: A Meta-analysis.

Ann Surg Oncol 2015 Oct 18;22(11):3695-700. Epub 2015 Feb 18.

Department of Obstetrics and Gynecology, CHA University School of Medicine, Seongnam, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4443-1DOI Listing
October 2015

Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo.

Gynecol Oncol 2015 Oct 8;139(1):112-7. Epub 2015 Aug 8.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, 333 Cedar Street New Haven, CT 06520, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587290PMC
October 2015

Review of Leiomyoma Variants.

AJR Am J Roentgenol 2015 Oct;205(4):912-21

4 Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://www.ajronline.org/doi/10.2214/AJR.14.13946
Publisher Site
http://dx.doi.org/10.2214/AJR.14.13946DOI Listing
October 2015

Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients.

Gynecol Oncol 2015 Jul 27;138(1):11-7. Epub 2015 Apr 27.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, PO Box 208063, New Haven, CT 06520-8063, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.04.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469551PMC
July 2015

A series of malignant ovarian cancers arising from within a mature cystic teratoma: a single institution experience.

Int J Gynecol Cancer 2015 Jun;25(5):792-7

*Section of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT; †Section of Gynecologic Oncology, University of Maryland Medical Center, Baltimore, MD; and ‡Departments of Obstetrics, Gynecology, and Reproductive Sciences, §Pathology, and ∥Diagnostic Radiology, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2015/06000/A_Series_of_Mal
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000431DOI Listing
June 2015

Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube cancers: A retrospective review.

Gynecol Oncol 2015 Jun 17;137(3):392-400. Epub 2015 Mar 17.

Yale University, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, P.O. Box 208063, New Haven, CT 06511, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.03.008DOI Listing
June 2015

Management of Borderline Ovarian Tumors Based on Patient and Tumor Characteristics.

Gynecol Obstet Invest 2015 Jun 6. Epub 2015 Jun 6.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Conn., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000431219DOI Listing
June 2015

The clinical impact of gynecologic MRI.

AJR Am J Roentgenol 2015 Mar;204(3):674-80

1 Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.14.12567DOI Listing
March 2015

High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma.

J Contemp Brachytherapy 2015 Feb 26;7(1):35-40. Epub 2015 Jan 26.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Gynecologic Oncology, Yale University School of Medicine, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/jcb.2015.48539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371058PMC
February 2015

Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivo.

Gynecol Oncol 2014 Nov 27;135(2):312-7. Epub 2014 Aug 27.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, PO Box 208063, New Haven, CT 06520-8063, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.08.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270135PMC
November 2014

Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo.

Gynecol Oncol 2014 Oct 12;135(1):142-8. Epub 2014 Aug 12.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258140125
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2014.08.006DOI Listing
October 2014

Appearances can be deceiving: ovarian mass presents as vaginal prolapse.

Am J Obstet Gynecol 2014 Sep 6;211(3):310.e1-2. Epub 2014 May 6.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2014.05.006DOI Listing
September 2014

Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.

Int J Gynecol Cancer 2014 Sep;24(7):1250-5

*Yale-New Haven Hospital; †Yale University School of Medicine, New Haven, CT; and ‡John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000201DOI Listing
September 2014

Endometrial adenocarcinoma presenting as a hematotrachelos.

Obstet Gynecol 2014 Aug;124(2 Pt 2 Suppl 1):448-51

Departments of Obstetrics, Gynecology, and Reproductive Sciences and Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/greenjournal/2014/08001/Endomet
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/AOG.0000000000000281DOI Listing
August 2014

Phase I clinical trial of the mammalian target of rapamycin inhibitor everolimus in combination with oral topotecan for recurrent and advanced endometrial cancer.

Int J Gynecol Cancer 2014 Mar;24(3):528-33

Sections of *Medical Oncology, and †Gynecologic Oncology, and ‡Department of Therapeutic Radiology, School of Medicine, Yale University, Yale Comprehensive Cancer Center, New Haven, CT; and §Novartis Pharmaceuticals Corp, East Hanover, NJ.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ijgc/2014/03000/Phase_I_Clinica
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/IGC.0000000000000085DOI Listing
March 2014

HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor.

Gynecol Oncol 2013 Dec 4;131(3):753-8. Epub 2013 Sep 4.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, PO Box 208063, New Haven, CT 06520-8063, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.08.033DOI Listing
December 2013

Cancerous 'floater': a lesson learned about tissue identity testing, endometrial cancer and microsatellite instability.

Mod Pathol 2013 Sep 5;26(9):1264-9. Epub 2013 Apr 5.

Department of Pathology, Yale University School of Medicine, New Haven, CT06520-8023 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2013.63DOI Listing
September 2013

Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.

Am J Obstet Gynecol 2013 Jul 10;209(1):62.e1-9. Epub 2013 Apr 10.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2013.04.017DOI Listing
July 2013

Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).

J Surg Oncol 2013 Feb 30;107(2):195-200. Epub 2012 May 30.

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jso.23171
Publisher Site
http://dx.doi.org/10.1002/jso.23171DOI Listing
February 2013

An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.

J Oncol Pharm Pract 2012 Sep 13;18(3):323-32. Epub 2012 Feb 13.

Department of Pharmacy, Smilow Cancer Hospital at Yale-New Haven, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155211435714DOI Listing
September 2012

Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression.

J Oncol 2011 30;2011:628084. Epub 2011 Nov 30.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208063, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/628084DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236522PMC
August 2012

Outcomes of small bowel obstruction in patients with previous gynecologic malignancies.

Am J Surg 2012 Apr 15;203(4):472-9. Epub 2011 Dec 15.

Department of Surgery, Yale University School of Medicine, Office of Surgical Education, New Haven, CT 06520-8062, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2011.07.013DOI Listing
April 2012

A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study.

Gynecol Oncol 2012 Mar 20;124(3):471-3. Epub 2011 Oct 20.

Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S009082581100799
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2011.09.029DOI Listing
March 2012

Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancer.

Gynecol Oncol 2012 Feb 29;124(2):260-4. Epub 2011 Oct 29.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06520-8063, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.09.038DOI Listing
February 2012

Development of targeted therapy in uterine serous carcinoma, a biologically aggressive variant of endometrial cancer.

Expert Rev Anticancer Ther 2012 Jan;12(1):41-9

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.11.192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287395PMC
January 2012

The significance of perineural invasion in early-stage cervical cancer.

Gynecol Oncol 2011 Dec 2;123(3):561-4. Epub 2011 Oct 2.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2011.08.028DOI Listing
December 2011

Vulvar ulcers and vulvar carcinoma.

Authors:
Peter E Schwartz

Menopause 2011 Oct;18(10):1042-3

View Article

Download full-text PDF

Source
October 2011

Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.

Int J Gynecol Cancer 2011 Apr;21(3):535-44

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Arizona, Tucson, AZ 85724, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31820c4c8dDOI Listing
April 2011

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Authors:
Antonis C Antoniou Jonathan Beesley Lesley McGuffog Olga M Sinilnikova Sue Healey Susan L Neuhausen Yuan Chun Ding Timothy R Rebbeck Jeffrey N Weitzel Henry T Lynch Claudine Isaacs Patricia A Ganz Gail Tomlinson Olufunmilayo I Olopade Fergus J Couch Xianshu Wang Noralane M Lindor Vernon S Pankratz Paolo Radice Siranoush Manoukian Bernard Peissel Daniela Zaffaroni Monica Barile Alessandra Viel Anna Allavena Valentina Dall'Olio Paolo Peterlongo Csilla I Szabo Michal Zikan Kathleen Claes Bruce Poppe Lenka Foretova Phuong L Mai Mark H Greene Gad Rennert Flavio Lejbkowicz Gord Glendon Hilmi Ozcelik Irene L Andrulis Mads Thomassen Anne-Marie Gerdes Lone Sunde Dorthe Cruger Uffe Birk Jensen Maria Caligo Eitan Friedman Bella Kaufman Yael Laitman Roni Milgrom Maya Dubrovsky Shimrit Cohen Ake Borg Helena Jernström Annika Lindblom Johanna Rantala Marie Stenmark-Askmalm Beatrice Melin Kate Nathanson Susan Domchek Ania Jakubowska Jan Lubinski Tomasz Huzarski Ana Osorio Adriana Lasa Mercedes Durán Maria-Isabel Tejada Javier Godino Javier Benitez Ute Hamann Mieke Kriege Nicoline Hoogerbrugge Rob B van der Luijt Christi J van Asperen Peter Devilee E J Meijers-Heijboer Marinus J Blok Cora M Aalfs Frans Hogervorst Matti Rookus Margaret Cook Clare Oliver Debra Frost Don Conroy D Gareth Evans Fiona Lalloo Gabriella Pichert Rosemarie Davidson Trevor Cole Jackie Cook Joan Paterson Shirley Hodgson Patrick J Morrison Mary E Porteous Lisa Walker M John Kennedy Huw Dorkins Susan Peock Andrew K Godwin Dominique Stoppa-Lyonnet Antoine de Pauw Sylvie Mazoyer Valérie Bonadona Christine Lasset Hélène Dreyfus Dominique Leroux Agnès Hardouin Pascaline Berthet Laurence Faivre Catherine Loustalot Tetsuro Noguchi Hagay Sobol Etienne Rouleau Catherine Nogues Marc Frénay Laurence Vénat-Bouvet John L Hopper Mary B Daly Mary B Terry Esther M John Saundra S Buys Yosuf Yassin Alexander Miron David Goldgar Christian F Singer Anne Catharina Dressler Daphne Gschwantler-Kaulich Georg Pfeiler Thomas V O Hansen Lars Jønson Bjarni A Agnarsson Tomas Kirchhoff Kenneth Offit Vincent Devlin Ana Dutra-Clarke Marion Piedmonte Gustavo C Rodriguez Katie Wakeley John F Boggess Jack Basil Peter E Schwartz Stephanie V Blank Amanda Ewart Toland Marco Montagna Cinzia Casella Evgeny Imyanitov Laima Tihomirova Ignacio Blanco Conxi Lazaro Susan J Ramus Lara Sucheston Beth Y Karlan Jenny Gross Rita Schmutzler Barbara Wappenschmidt Christoph Engel Alfons Meindl Magdalena Lochmann Norbert Arnold Simone Heidemann Raymonda Varon-Mateeva Dieter Niederacher Christian Sutter Helmut Deissler Dorothea Gadzicki Sabine Preisler-Adams Karin Kast Ines Schönbuchner Trinidad Caldes Miguel de la Hoya Kristiina Aittomäki Heli Nevanlinna Jacques Simard Amanda B Spurdle Helene Holland Xiaoqing Chen Radka Platte Georgia Chenevix-Trench Douglas F Easton

Cancer Res 2010 Dec 30;70(23):9742-54. Epub 2010 Nov 30.

Center for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1907DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999830PMC
December 2010

Fifth Alon Dembo memorial workshop: case 3.

Authors:
Peter E Schwartz

Int J Gynecol Cancer 2010 Oct;20(11 Suppl 2):S24-6

Yale University School of Medicine, New Haven, CT 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/IGC.0b013e3181f60ad0DOI Listing
October 2010